Kate Hermans serves as Executive at Ambrx Biopharma Inc., where they oversee executive responsibilities. Since joining the company, Kate Hermans has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 7, 2023 involved receiving (via award) 85,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 7, 2023 | AMAM | $0 | Award | 85,000 | $N/A | Discretionary |
Kate Hermans currently holds 85,000 shares of Ambrx Biopharma Inc. (AMAM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kate Hermans has been a net neutral trader of AMAM stock. They have purchased $0 and sold $0 worth of shares.
Kate Hermans's most recent insider trade was on Jun 7, 2023, when they sold 85,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted